The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2022 | Novel strategies to evaluate biomarkers of interest in multiple myeloma
In this video, Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, outlines the importance of integrating novel biomarkers in multiple myeloma (MM) research, and further comments on novel models and strategies being used in this space. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
